Glenmark, SaNOtize sign deal for anti-COVID-19 nasal spray in India

Glenmark Pharmaceuticals on Monday said that it has signed an agreement with Canada's SaNOtize Research and Development to commercialise its nasal spray for COVID-19 treatment in India and other Asian countries. According to Glenmark, the nasal spray is designed to kill the coronavirus in the upper airways. Its based on nitric oxide (NO) and is effective against SARS-CoV-2, Glenmark added.